Frauke M. Schnorfeil

Martinsried, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study.

A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study.

Journal: Vaccine

Published: April 17, 2024

WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.

WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.

Journal: Leukemia

Published: January 16, 2023

Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial.

Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial.

Journal: Clinical & translational immunology

Published: November 25, 2019

Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disorders.

Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disorders.

Journal: Annals of neurology

Published: July 18, 2018

Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML.

Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML.

Journal: Leukemia

Published: December 24, 2017

Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells.

Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells.

Journal: Frontiers in immunology

Published: October 08, 2017

T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment.

T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment.

Journal: Journal of hematology & oncology

Published: February 25, 2015

Current strategies in immunotherapy for acute myeloid leukemia.

Current strategies in immunotherapy for acute myeloid leukemia.

Journal: Immunotherapy

Published: December 22, 2012

MicroRNAs regulate dendritic cell differentiation and function.

MicroRNAs regulate dendritic cell differentiation and function.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: October 05, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026